These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6440790)

  • 1. Stereoselective disposition of RS-tocainide in man.
    Hoffmann KJ; Renberg L; Bäärnhielm C
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):215-22. PubMed ID: 6440790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis and stereoselective metabolism after separate oral doses of tocainide enantiomers to healthy volunteers.
    Hoffmann KJ; Renberg L; Gyllenhaal O
    Biopharm Drug Dispos; 1990; 11(4):351-63. PubMed ID: 2111189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective pharmacokinetics of tocainide in human uraemic patients and in healthy subjects.
    McErlane KM; Axelson J; Vaughan R; Kerr CR; Price JD; Igwemezie L; Pillai G
    Eur J Clin Pharmacol; 1990; 39(4):373-6. PubMed ID: 2127569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gas--liquid chromatographic resolution and assay of tocainide enantiomers using a chiral capillary column and study of their selective disposition in man.
    McErlane KM; Pillai GK
    J Chromatogr; 1983 May; 274():129-38. PubMed ID: 6409913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of (R,S)-tocainide. Some stereoselective aspects.
    Gal J; French TA; Zysset T; Haroldsen PE
    Drug Metab Dispos; 1982; 10(4):399-404. PubMed ID: 6126341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of rifampin on tocainide pharmacokinetics in humans.
    Rice TL; Patterson JH; Celestin C; Foster JR; Powell JR
    Clin Pharm; 1989 Mar; 8(3):200-5. PubMed ID: 2495879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of tocainide in patients with severe renal failure.
    Braun J; Sörgel F; Engelmaier F; Gluth WP; Gessler U
    Eur J Clin Pharmacol; 1985; 28(6):665-70. PubMed ID: 3933983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tocainide in patients with renal dysfunction and during haemodialysis.
    Wiegers U; Hanrath P; Kuck KH; Pottage A; Graffner C; Augustin J; Runge M
    Eur J Clin Pharmacol; 1983; 24(4):503-7. PubMed ID: 6407848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of tocainide in patients with combined hepatic and renal dysfunction.
    Oltmanns D; Pottage A; Endell W
    Eur J Clin Pharmacol; 1983; 25(6):787-90. PubMed ID: 6420165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gas chromatographic assay for tocainide carbamoyl-O-beta-D-glucuronide:quantitation of the base hydrolyzed product, 3-(2',6'-xylyl)-5-methylhydantoin.
    Kwok DW; McErlane KM; Axelson JE
    Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):395-409. PubMed ID: 2111573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of the enantiomers of tocainide in blood plasma using gas-liquid chromatography with electron-capture detection.
    Sedman AJ; Gal J
    J Chromatogr; 1984 Mar; 306():155-64. PubMed ID: 6425350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific salivary excretion of tocainide enantiomers in man.
    Pillai GK; Axelson JE; Kerr CR; McErlane KM
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):209-21. PubMed ID: 6424192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum binding of tocainide and its enantiomers in human subjects.
    Sedman AJ; Bloedow DC; Gal J
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):165-8. PubMed ID: 6815740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical pharmacology of lidocaine congeners--review of encainide, flecainide, lorcainide and tocainide.
    McDevitt DG
    Eur Heart J; 1984 Sep; 5 Suppl B():63-6. PubMed ID: 6437818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of tocainide in the rat.
    Venkataramanan R; Abbott FS; Axelson JE
    J Pharm Sci; 1982 May; 71(5):491-4. PubMed ID: 6808112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-(2,6-Xylyl)-5-methylhydantoin--a metabolite or a metabonate of tocainide in rats.
    Venkataramanan R; Axelson JE
    Xenobiotica; 1981 Apr; 11(4):259-65. PubMed ID: 6795837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.
    Upward JW; Holt D; Emery P; Akhras F; Jackson G
    Eur J Clin Pharmacol; 1983; 25(5):589-94. PubMed ID: 6420162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocainide pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Raehl CL; Beirne GJ; Moorthy AV; Patel AK
    Am J Cardiol; 1987 Sep; 60(8):747-50. PubMed ID: 3116834
    [No Abstract]   [Full Text] [Related]  

  • 20. Stereospecific high-performance liquid chromatographic determination of tocainide.
    Carr RA; Foster RT; Freitag D; Pasutto FM
    J Chromatogr; 1991 May; 566(1):155-62. PubMed ID: 1909341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.